Structures by: Hökelek T.
Total: 381
(1SR,2SR,3SR,10SR,12RS,13RS,14RS,17SR)-13-Hydroxy-11- oxapentacyclo[8.7.0.0^2,14^.0^4,9^.0^12,17^]heptadeca-4,6,8-trien-3-yl 4-chlorobenzoate
C23H21ClO4
Acta Crystallographica Section E (2005) 61, 11 o3859-o3861
a=13.6103(5)Å b=12.5787(6)Å c=21.6102(8)Å
α=90.00° β=94.479(3)° γ=90.00°
2-Amino-4-(4'-methoxyphenyl)-1,3-thiazole
C10H10N2OS
Acta Crystallographica Section E (2006) 62, 4 o1609-o1611
a=7.181(2)Å b=7.750(2)Å c=17.994(3)Å
α=90.00° β=90.00° γ=90.00°
C16H22N2
C16H22N2
Acta Crystallographica Section E (2001) 57, 7 o568-o570
a=7.9665(10)Å b=8.911(10)Å c=10.7318(10)Å
α=69.59(6)° β=75.783(10)° γ=80.87(8)°
C7H7Br5
C7H7Br5
Acta Crystallographica Section E (2001) 57, 8 o709-o711
a=6.765(2)Å b=13.822(2)Å c=12.114(3)Å
α=90.00° β=94.92(2)° γ=90.00°
C12H7BrN2O
C12H7BrN2O
Acta Crystallographica Section E (2001) 57, 7 o645-o647
a=14.446(3)Å b=3.9630(10)Å c=17.807(7)Å
α=90° β=98.59(2)° γ=90°
C25H18Cl2N5O6P3
C25H18Cl2N5O6P3
Acta Crystallographica Section E (2001) 57, 11 o1063-o1066
a=9.9482(10)Å b=11.2184(10)Å c=12.8536(10)Å
α=97.702(7)° β=105.515(7)° γ=94.503(7)°
C11H15N3O2
C11H15N3O2
Acta Crystallographica Section E (2001) 57, 12 o1247-o1249
a=8.404(2)Å b=7.672(2)Å c=17.592(3)Å
α=90.00° β=102.620(19)° γ=90.00°
C14H12Br2
C14H12Br2
Acta Crystallographica Section E (2004) 60, 4 o703-o705
a=11.7056(9)Å b=6.9920(5)Å c=14.6897(11)Å
α=90.00° β=92.0520(10)° γ=90.00°
C10H10N2,C4H8N2O2
C10H10N2,C4H8N2O2
Acta Crystallographica Section E (2001) 57, 8 o663-o665
a=7.9814(10)Å b=8.2719(10)Å c=12.168(3)Å
α=91.779(18)° β=106.668(14)° γ=111.018(10)°
C21H24N2O2
C21H24N2O2
Acta Crystallographica Section E (2001) 57, 4 o309-o311
a=14.231(8)Å b=15.6630(14)Å c=8.206(4)Å
α=90.00° β=103.044(8)° γ=90.00°
C22H15Cl4N4O2P3
C22H15Cl4N4O2P3
Acta Crystallographica Section E (2004) 60, 6 o971-o973
a=9.6154(7)Å b=11.5957(10)Å c=13.1996(15)Å
α=66.198(8)° β=74.053(8)° γ=67.858(6)°
2-Amino-5-(p-nitrophenylsulfonyl)-1,3-thiazole
C9H7N3O4S2
Acta Crystallographica Section E (2006) 62, 7 o2634-o2636
a=8.6310(2)Å b=12.4943(3)Å c=11.4911(4)Å
α=90.00° β=110.874(2)° γ=90.00°
N-{4-[(2-Phenyl-1H-indol-3-yl)diazenyl]phenyl}acetamide
C22H18N4O
Acta Crystallographica Section E (2006) 62, 8 o3492-o3494
a=5.996(5)Å b=14.786(5)Å c=20.531(5)Å
α=90° β=90° γ=90°
C14H13Cl
C14H13Cl
Acta Crystallographica Section E (2004) 60, 3 o350-o352
a=8.0400(8)Å b=7.8514(7)Å c=18.1877(16)Å
α=90.00° β=101.133(2)° γ=90.00°
Diethyl 7-oxo-3-(pyrrolidin-1-yl)cycloocta-2,8-diene-1,2-dicarboxylate
C18H25NO5
Acta Crystallographica Section E (2004) 60, 1 o48-o50
a=16.3870(16)Å b=9.5645(12)Å c=11.3393(19)Å
α=90.00° β=82.044(10)° γ=90.00°
N-Hydroxy-N'-(1-naphthyl)-2-phenylacetamidin-2-one
C18H14N2O2
Acta Crystallographica Section E (2004) 60, 1 o109-o111
a=12.0073(11)Å b=8.4530(9)Å c=15.0167(15)Å
α=90.00° β=94.188(8)° γ=90.00°
N-(p-Nitrophenylsulfonyl)-1H-pyrrole
C10H8N2O4S
Acta Crystallographica Section E (2004) 60, 12 o2488-o2490
a=12.7169(17)Å b=7.5317(13)Å c=11.2959(12)Å
α=90.00° β=93.381(12)° γ=90.00°
(1RS,4RS)-1-Methoxyspiro[bicyclo[2.2.2]oct-5-ene-2,2'-[1',3']dithiolane]
C11H16OS2
Acta Crystallographica Section E (2006) 62, 2 e6-e7
a=6.748(4)Å b=7.870(4)Å c=11.474(7)Å
α=99.23(4)° β=103.00(5)° γ=102.69(3)°
4-Ethyl-6,6-ethylenedithio-2-(2-methoxyethyl)-7-methoxymethylene- 2,3,4,5,6,7-hexahydro-1,5-methano-1H-azocino[4,3-b]indol-3-one
C23H30N2O3S2
Acta Crystallographica Section E (2006) 62, 2 o791-o793
a=15.897(3)Å b=7.0394(14)Å c=21.195(3)Å
α=90.00° β=111.164(13)° γ=90.00°
C18H15NO3S
C18H15NO3S
Acta Crystallographica Section C (1994) 50, 3 450-453
a=8.952(5)Å b=21.979(4)Å c=15.709(3)Å
α=90.° β=90.° γ=90.°
C14H15NS2
C14H15NS2
Acta Crystallographica Section C (1994) 50, 3 450-453
a=9.715(2)Å b=6.721(2)Å c=19.854(8)Å
α=90.° β=91.29(3)° γ=90.°
C14H21Cl9N6OP6
C14H21Cl9N6OP6
Acta Crystallographica Section C (1994) 50, 3 453-456
a=11.933(2)Å b=16.400(3)Å c=9.471(3)Å
α=92.20(2)° β=118.15(2)° γ=93.85(3)°
C27H32N2O4S2
C27H32N2O4S2
Acta Crystallographica Section C (1999) 55, 4 675-677
a=10.2230(10)Å b=11.4800(10)Å c=12.0580(10)Å
α=81.619(8)° β=70.668(6)° γ=87.605(6)°
C26H26CoN4O8
C26H26CoN4O8
Acta Crystallographica Section C (1999) 55, 4 545-547
a=7.1630(10)Å b=18.2990(10)Å c=10.4070(10)Å
α=90° β=109.550(10)° γ=90°
C34H38CuN4O6
C34H38CuN4O6
Acta Crystallographica Section C (1996) 52, 10 2470-2473
a=10.006(1)Å b=14.876(1)Å c=11.340(1)Å
α=90° β=102.93(1)° γ=90°
C26H26N4O10Cu
C26H26N4O10Cu
Acta Crystallographica Section C (1998) 54, 3 347-348
a=11.4376(10)Å b=9.8396(9)Å c=12.5356(11)Å
α=90° β=101.453(7)° γ=90°
C44H26N12O38Cu4
C44H26N12O38Cu4
Acta Crystallographica Section C (1998) 54, 3 310-313
a=11.6080(10)Å b=11.9860(10)Å c=12.7750(10)Å
α=73.426(7)° β=71.549(7)° γ=62.478(7)°
C14H13NOS2
C14H13NOS2
Acta Crystallographica Section C (1998) 54, 9 1297-1299
a=7.5370(10)Å b=16.9280(10)Å c=10.2920(10)Å
α=90° β=106.044(5)° γ=90°
C26H24CoN6O12
C26H24CoN6O12
Acta Crystallographica Section C (1998) 54, 9 1242-1244
a=7.5815(8)Å b=9.9861(9)Å c=10.2413(12)Å
α=78.417(9)° β=88.559(9)° γ=71.491(8)°
C34H40CuN6O12
C34H40CuN6O12
Acta Crystallographica Section C (1997) 53, 8 1049-1051
a=7.40830(10)Å b=8.51720(10)Å c=14.94250(10)Å
α=87.420(10)° β=78.710(10)° γ=77.570(10)°
C6H14Cl4N2OP2
C6H14Cl4N2OP2
Acta Crystallographica Section C (1998) 54, 4 523-525
a=10.8018(9)Å b=12.5581(9)Å c=10.9691(9)Å
α=90° β=91.052(7)° γ=90°
C48H48Cu2N4O10
C48H48Cu2N4O10
Acta Crystallographica Section C (1995) 51, 10 2020-2023
a=10.881(2)Å b=19.772(3)Å c=21.563(3)Å
α=90° β=90° γ=90°
C12H7FN2
C12H7FN2
Acta Crystallographica Section C (1991) 47, 7 1432-1434
a=11.296(4)Å b=8.471(3)Å c=18.889(2)Å
α=90° β=98.83(2)° γ=90°
C28H28N2NiO2
C28H28N2NiO2
Acta Crystallographica Section C (1995) 51, 5 880-884
a=10.655(5)Å b=10.688(5)Å c=12.575(5)Å
α=119.27(3)° β=96.56(3)° γ=103.23(4)°
C15H23Cl7N4OP4
C15H23Cl7N4OP4
Acta Crystallographica Section C (1996) 52, 12 3243-3246
a=10.029(1)Å b=11.051(1)Å c=13.794(1)Å
α=71.81(1)° β=73.87(1)° γ=73.61(1)°
C44H26Cl4N4
C44H26Cl4N4
Acta Crystallographica Section C (1993) 49, 9 1667-1670
a=15.776(13)Å b=8.646(3)Å c=14.087(5)Å
α=90° β=96.05(5)° γ=90°
C48H48N4O14Zn2,2H2O
C48H48N4O14Zn2,2H2O
Acta Crystallographica Section C (1996) 52, 5 1128-1131
a=8.681(3)Å b=11.772(2)Å c=23.730(6)Å
α=90° β=95.8(2)° γ=90°
Co(NO2C6H3CO2)2,4(H2O)
Co(NO2C6H3CO2)2,4(H2O)
Acta Crystallographica Section C (1997) 53, 2 176-179
a=5.140(2)Å b=14.784(3)Å c=11.941(2)Å
α=90.0° β=97.54(5)° γ=90.0°
Zn(NO2C6H3CO2)2,4(H2O)
Zn(NO2C6H3CO2)2,4(H2O)
Acta Crystallographica Section C (1997) 53, 2 176-179
a=5.145(3)Å b=14.772(2)Å c=11.936(2)Å
α=90.0° β=97.56(4)° γ=90.0°
[Co(C7H5O3)2(C10H14N2O)2(H2O)2]
[Co(C7H5O3)2(C10H14N2O)2(H2O)2]
Acta Crystallographica Section C (1997) 53, 2 187-189
a=7.627(1)Å b=9.054(1)Å c=14.600(1)Å
α=78.64(1)° β=84.91(1)° γ=63.67(1)°
C22H26N2O3
C22H26N2O3
Acta Crystallographica Section C (1999) 55, 3 381-383
a=8.0010(10)Å b=15.6390(10)Å c=16.4050(10)Å
α=90° β=94.150(10)° γ=90°
C12H7N3O2
C12H7N3O2
Acta Crystallographica Section C (1999) 55, 3 383-385
a=7.8940(10)Å b=13.8920(10)Å c=9.5560(10)Å
α=90° β=103.28(2)° γ=90°
C18H19NO2S2
C18H19NO2S2
Acta Crystallographica Section C (1999) 55, 1 114-116
a=9.2020(10)Å b=18.870(3)Å c=19.138(2)Å
α=90° β=90° γ=90°
C21H24N2O3
C21H24N2O3
Acta Crystallographica Section C (1999) 55, 2 248-250
a=14.901(2)Å b=15.7850(10)Å c=8.012(2)Å
α=90° β=98.67(2)° γ=90°
C15H23Cl5N3OP3
C15H23Cl5N3OP3
Acta Crystallographica Section C (1999) 55, 5 783-785
a=10.3860(10)Å b=22.5010(10)Å c=11.1140(10)Å
α=90° β=110.08(3)° γ=90°
C34H72N12P4
C34H72N12P4
Acta Crystallographica Section C (1999) 55, 6 983-985
a=13.0880(10)Å b=8.7650(10)Å c=18.7170(10)Å
α=90° β=97.770(10)° γ=90°
C26H26CoN4O10
C26H26CoN4O10
Acta Crystallographica Section C (1999) 55, 9 1438-1440
a=7.2140(10)Å b=18.3400(10)Å c=10.4180(10)Å
α=90° β=109.320(10)° γ=90°
Diaquabis(4-bromobenzoato-κ<i>O</i>)bis(<i>N</i>,<i>N</i>- diethylnicotinamide-κ<i>N</i>^1^)zinc(II)
C34H40Br2N4O8Zn
Acta Crystallographica Section E (2008) 64, 9 m1218-m1219
a=7.3761(14)Å b=8.677(2)Å c=16.072(3)Å
α=84.32(2)° β=78.917(17)° γ=67.029(18)°
1-Methyl-2-phenyl-3-(thiadiazol-2-yldiazenyl)-1H-indole
C17H13N5S
Acta Crystallographica Section E (2007) 63, 1 o148-o150
a=8.0288(2)Å b=17.3757(3)Å c=11.1899(3)Å
α=90.00° β=104.4222(14)° γ=90.00°
1,2-Dimethyl-3-(thiazol-2-yldiazenyl)-1H-indole
C13H12N4S
Acta Crystallographica Section E (2007) 63, 1 o351-o353
a=8.7257(2)Å b=10.3070(2)Å c=14.4948(6)Å
α=83.828(6)° β=88.489(6)° γ=79.757(5)°
1-Methyl-2-phenyl-3-(5-ethyl-1,3,4-thiadiazol-2-yldiazenyl)-1H-indole
C19H17N5S
Acta Crystallographica Section E (2007) 63, 2 o568-o570
a=10.7629(14)Å b=10.0115(8)Å c=16.568(2)Å
α=90.00° β=99.664(6)° γ=90.00°
6-Amino-1,3-dimethyl-5-(4-methylthiazol-2-yldiazenyl)uracil
C10H12N6O2S
Acta Crystallographica Section E (2007) 63, 2 o571-o573
a=9.3604(3)Å b=10.3052(3)Å c=13.2638(5)Å
α=90.00° β=93.391(2)° γ=90.00°
Diaquabis(4-chlorobenzoato-κ<i>O</i>)bis(nicotinamide-κ<i>N</i>)cobalt(II)
C26H24Cl2CoN4O8
Acta Crystallographica Section E (2007) 63, 5 m1344-m1346
a=7.5945(2)Å b=9.9333(2)Å c=10.0701(3)Å
α=78.900(10)° β=86.840(10)° γ=71.55(2)°
1-Methyl-3-(5-methylthiazol-2-yldiazenyl)-2-phenyl-1H-indole
C19H16N4S
Acta Crystallographica Section E (2007) 63, 7 o3281-o3282
a=9.2514(7)Å b=9.2745(5)Å c=11.0971(6)Å
α=106.2590(10)° β=106.542(2)° γ=103.337(2)°
Diaquabis(4-bromobenzoato-κO)bis(nicotinamide-κN^1^)cobalt(II)
C26H24Br2CoN4O8
Acta Crystallographica Section E (2007) 63, 7 m1873-m1874
a=7.62020(10)Å b=9.9593(3)Å c=10.1125(2)Å
α=77.920(10)° β=85.650(10)° γ=71.65(2)°
2-(1H-Benzimidazol-1-yl)-1-phenylethanone oxime
C15H13N3O
Acta Crystallographica Section E (2007) 63, 8 o3463-o3464
a=9.32950(10)Å b=11.2863(2)Å c=12.5962(2)Å
α=90° β=90° γ=90°
(1Z,2E)-1-(3,5-Dimethyl-1H-pyrazol-1-yl)-1,2-ethanedione dioxime
C7H10N4O2
Acta Crystallographica Section E (2007) 63, 8 o3601-o3601
a=9.7598(5)Å b=9.8572(6)Å c=9.8140(7)Å
α=90° β=104.254(3)° γ=90°
2-(1H-Benzimidazol-1-yl)-1-(2-furyl)-3-phenylpropan-1-one
C20H16N2O2
Acta Crystallographica Section E (2007) 63, 8 o3638-o3638
a=16.3886(2)Å b=6.5976(2)Å c=16.7166(3)Å
α=90.00° β=114.677(9)° γ=90.00°
N,N-Bis[2-(2-furyl)-2-(hydroxyimino)ethyl]aniline
C18H17N3O4
Acta Crystallographica Section E (2007) 63, 9 o3827-o3828
a=11.2363(2)Å b=11.9889(3)Å c=12.8785(4)Å
α=90.00° β=109.886(10)° γ=90.00°
(3aR,10bR)-3a,4,10,10b-Tetrahydro-2H-furo[2,3-a]carbazol-5(3H)-one
C14H13NO2
Acta Crystallographica Section E (2007) 63, 9 o3913-o3914
a=9.5970(2)Å b=10.0316(3)Å c=12.4952(3)Å
α=98.498(15)° β=107.499(18)° γ=96.362(19)°
2-(1H-Benzimidazol-1-yl)-1-(furan-2-yl)ethanone O-2,4-dichlorobenzyloxime
C20H15Cl2N3O2
Acta Crystallographica Section E (2007) 63, 10 o4090-o4091
a=9.44070(10)Å b=5.3902(2)Å c=18.6522(3)Å
α=90.00° β=94.036(10)° γ=90.00°
Diaquabis(N,N-diethylnicotinamide-κN)bis(4-fluorobenzoato-κO)zinc(II)
C34H40F2N4O8Zn
Acta Crystallographica Section E (2007) 63, 10 m2561-m2562
a=7.4261(2)Å b=8.7188(3)Å c=15.0798(4)Å
α=98.44(2)° β=95.73(2)° γ=112.94(3)°
2-Hydroxyimino-1-phenylethanone thiosemicarbazone monohydrate
C9H10N4OS,H2O
Acta Crystallographica Section E (2008) 64, 3 o623-o624
a=28.5615(3)Å b=4.6805(3)Å c=22.0977(4)Å
α=90.00° β=127.24(2)° γ=90.00°
1-[2-(3,4-Dichlorobenzyloxy)-2-phenylethyl]-1<i>H</i>-benzimidazole
C22H18Cl2N2O
Acta Crystallographica Section E (2008) 64, 8 o1588-o1589
a=14.4664(3)Å b=7.3995(2)Å c=19.1030(3)Å
α=90.00° β=111.6530(10)° γ=90.00°
2-(2,2-Dimethoxyethyl)-3-oxo-1,2,3,4,5,6-hexahydro-1,5-methano- 7H-azocino[4,3-b]indole
C18H22N2O3
Acta Crystallographica Section E (2007) 63, 7 o3268-o3268
a=10.0347(4)Å b=8.4616(7)Å c=20.1168(9)Å
α=90.00° β=103.750(3)° γ=90.00°
1-Methyl-2-phenyl-1H-indole
C15H13N
Acta Crystallographica Section E (2007) 63, 4 o1963-o1964
a=8.19570(10)Å b=15.8652(3)Å c=17.1653(3)Å
α=90.0° β=90.0° γ=90.0°
Diaquabis[4-(dimethylamino)benzoato-κO](nicotinamide-κN^1^)cobalt(II) dihydrate
C30H36CoN6O8,2(H2O)
Acta Crystallographica Section E (2007) 63, 4 m1078-m1080
a=8.198(2)Å b=9.9680(10)Å c=10.2003(9)Å
α=76.252(9)° β=89.100(10)° γ=78.290(10)°
3-[5,6-Dimethyl-1,3-benzothiazol-2-yl)diazenyl]-1-methyl-2-phenyl- 1<i>H</i>-indole
C24H20N4S
Acta Crystallographica Section E (2007) 63, 7 o3170-o3170
a=13.171(5)Å b=9.815(2)Å c=17.257(4)Å
α=90° β=112.31(2)° γ=90°
C17H15N3O2
C17H15N3O2
Acta Crystallographica Section E (2006) 62, 9 o4130-o4131
a=10.5985(3)Å b=11.2970(2)Å c=12.7652(3)Å
α=90.00° β=107.6970(10)° γ=90.00°
5,3'-Dihydroxy-3,6,7,4'-tetramethoxyflavone
C19H18O8
Acta Crystallographica Section E (2006) 62, 9 o4159-o4161
a=15.5353(5)Å b=12.4493(3)Å c=17.6655(3)Å
α=90.00° β=92.424(2)° γ=90.00°
5-[(5-Methylthiazol-2-yl)diazenyl]pyrimidine-2,4,6(1H,3H,5H)-trione
C8H7N5O3S
Acta Crystallographica Section E (2007) 63, 3 o1506-o1508
a=13.092(2)Å b=7.0989(9)Å c=12.913(2)Å
α=90.00° β=116.321(7)° γ=90.00°
Tetraaquabis[4-(dimethylamino)benzoato-κO]manganese(II) dihydrate
C18H28MnN2O8,2H2O
Acta Crystallographica Section E (2007) 63, 3 m821-m823
a=7.2047(13)Å b=26.101(4)Å c=12.141(2)Å
α=90.00° β=90.00° γ=90.00°
3-(6-Methoxybenzothiazol-2-yldiazenyl)-1-methyl-2-phenyl-1<i>H</i>-indole
C23H18N4OS
Acta Crystallographica Section E (2007) 63, 6 o2837-o2839
a=7.3672(2)Å b=17.9326(5)Å c=15.0284(3)Å
α=90.00° β=99.70(2)° γ=90.00°
1-Phenyl-2-(1<i>H</i>-1,2,4-triazol-1-yl)ethanol
C10H11N3O
Acta Crystallographica Section E (2008) 64, 7 o1254
a=11.5356(2)Å b=10.1173(2)Å c=8.7127(2)Å
α=90.00° β=108.5810(10)° γ=90.00°
3-(5-Methylsulfanyl-1,3,4-thiadiazol-2-yldiazenyl)-1,2-methyl-1H-indole
C13H13N5S2
Acta Crystallographica Section E (2007) 63, 5 o2263-o2264
a=7.2739(2)Å b=13.4818(2)Å c=14.7373(4)Å
α=78.488(4)° β=87.707(5)° γ=85.551(5)°
Diaquabis(4-fluorobenzoato-κO)bis(nicotinamide-κN^1^)cobalt(II)
C26H24CoF2N4O8
Acta Crystallographica Section E (2007) 63, 5 m1341-m1343
a=12.003(2)Å b=8.928(4)Å c=12.4219(18)Å
α=90.00° β=90.434(13)° γ=90.00°
C14H13NO2
C14H13NO2
Acta Crystallographica Section E (2008) 64, 9 o1818-o1819
a=20.935(2)Å b=4.7151(10)Å c=12.276(3)Å
α=90.00° β=106.623(14)° γ=90.00°
2-(1<i>H</i>-Benzimidazol-1-yl)-1-phenylethanone
C15H12N2O
Acta Crystallographica Section E (2008) 64, 7 o1358
a=5.0475(2)Å b=11.2319(6)Å c=10.3517(5)Å
α=90.00° β=96.620(3)° γ=90.00°
1,3-Dimethyl-5-(thiazol-2-yldiazenyl)pyrimidine-2,4,6(1H,3H,5H)-trione
C9H9N5O3S
Acta Crystallographica Section E (2006) 62, 12 o5855-o5857
a=15.3047(5)Å b=7.4568(2)Å c=19.5403(5)Å
α=90.00° β=92.152(2)° γ=90.00°
Diaquabis[4-(dimethylamino)benzoato-κO](nicotinamide-κN^1^)manganese(II) dihydrate
C30H36MnN6O8,2(H2O)
Acta Crystallographica Section E (2007) 63, 5 m1279-m1281
a=8.1979(2)Å b=10.0888(2)Å c=10.2559(3)Å
α=76.465(2)° β=88.984(3)° γ=77.442(3)°
Ethyl [2-(2-phenyl-1H-indol-3-yldiazenyl)-1,3-thiazol-4-yl]acetate
C21H18N4O2S
Acta Crystallographica Section E (2006) 62, 9 o3835-o3837
a=10.61110(10)Å b=10.5040(2)Å c=17.3345(2)Å
α=90.00° β=100.2480(10)° γ=90.00°
Ethyl 2-{[(2-phenyl-1H-indol-3-yl)diazenyl]thiazol-4-yl}acetate
C22H20N4O2S
Acta Crystallographica Section E (2006) 62, 12 o5488-o5489
a=9.5545(3)Å b=16.5418(2)Å c=13.1399(3)Å
α=90.00° β=101.07(11)° γ=90.00°
3-(5-Ethyl-1,3,4-thiadiazol-2-yldiazenyl)-1,2-dimethyl-1H-indole
C14H15N5S1
Acta Crystallographica Section E (2007) 63, 5 o2265-o2266
a=8.18790(10)Å b=8.2359(2)Å c=10.5343(3)Å
α=92.560(10)° β=96.66(2)° γ=92.31(3)°
N-(4-Methylbenzyl)-N-(6-methyl-2-pyridyl)benzenesulfonamide
C20H20N2O2S
Acta Crystallographica Section E (2007) 63, 5 o2261-o2262
a=8.83860(10)Å b=9.8790(2)Å c=10.5647(2)Å
α=89.589(5)° β=82.226(6)° γ=81.737(8)°
Diaquabis(4-bromobenzoato-κ^2^O,O)zinc(II)
C14H12Br2O6Zn
Acta Crystallographica Section E (2008) 64, 3 m458-m459
a=26.9067(3)Å b=5.0704(4)Å c=12.0371(5)Å
α=90.00° β=104.95(2)° γ=90.00°
Bis(4-fluorobenzoato-κ^2^O,O)bis(nicotinamide-κN^1^)zinc(II) monohydrate
C26H20F2N4O6Zn,H2O
Acta Crystallographica Section E (2008) 64, 3 m460-m461
a=8.2363(2)Å b=12.3711(2)Å c=14.8971(3)Å
α=113.178(14)° β=99.015(17)° γ=99.465(16)°
Diaquabis(4-chlorobenzoato-κO)bis(N,N-diethylnicotinamide-κN^1^)manganese(II)
C34H40Cl2MnN4O8
Acta Crystallographica Section E (2008) 64, 3 m505-m506
a=7.35520(10)Å b=8.6465(2)Å c=15.9847(3)Å
α=84.500(16)° β=78.616(17)° γ=68.154(17)°
1-[2-(2,6-Dichlorobenzyloxy)-2-(2-furyl)ethyl]-1<i>H</i>-benzimidazole
C20H16Cl2N2O2
Acta Crystallographica Section E (2008) 64, 8 o1437
a=12.7720(3)Å b=12.9761(2)Å c=21.9732(5)Å
α=90.00° β=90.00° γ=90.00°
1-[2-(4-Fluorobenzyloxy)-2-phenylethyl]-1<i>H</i>-benzimidazole
C22H19FN2O
Acta Crystallographica Section E (2008) 64, 8 o1496-o1497
a=12.6946(2)Å b=18.1279(4)Å c=15.3547(3)Å
α=90.00° β=95.7470(10)° γ=90.00°
1-Phenyl-2-(1<i>H</i>-1,2,4-triazol-1-yl)ethanone
C10H9N3O
Acta Crystallographica Section E (2008) 64, 8 o1604
a=9.3129(2)Å b=8.11660(10)Å c=24.0475(4)Å
α=90.00° β=90.00° γ=90.00°
1-{2-Phenyl-2-[4-(trifluoromethyl)benzyloxy]ethyl}-1<i>H</i>-benzimidazole
C23H19F3N2O
Acta Crystallographica Section E (2008) 64, 8 o1655-o1656
a=39.3006(15)Å b=9.5834(2)Å c=23.0120(9)Å
α=90.00° β=113.6680(10)° γ=90.00°
1-[2-(4-Bromobenzyloxy)-2-phenylethyl]-1<i>H</i>-1,2,4-triazole
C17H16BrN3O
Acta Crystallographica Section E (2008) 64, 10 o1914-o1915
a=10.2070(2)Å b=13.7948(3)Å c=11.4007(2)Å
α=90.00° β=100.3170(10)° γ=90.00°
4-{[(1E)-(2-Hydroxyphenyl)methylidene]amino}-1,5-dimethyl-2-phenyl-1,2-dihydro -3H-pyrazol-3-one
C18H17N3O2
Acta Crystallographica Section C (2001) 57, 1 117-119
a=7.5950(10)Å b=7.4980(10)Å c=27.277(2)Å
α=90° β=95.332(7)° γ=90°
4,4,6,6-Tetrachlorocyclo-2,2-(propylenedioxydi-o-phenylenediimino)- 2λ^5^,4λ^5^,6λ^5^-triazatriphosphorine
C15H16Cl4N5O2P3
Acta Crystallographica Section C (2004) 60, 6 o381-o383
a=7.7094(6)Å b=22.404(2)Å c=12.6960(14)Å
α=90.00° β=93.751(7)° γ=90.00°
1,14-Dioxa-5,10-diaza-2,3:12,13-dibenzocyclooctadeca-2,12-diene monohydrate
C22H30N2O2,H2O
Acta Crystallographica Section C (2004) 60, 4 o278-o280
a=8.6247(12)Å b=14.7854(10)Å c=16.6181(14)Å
α=90.00° β=99.352(12)° γ=90.00°
C45H55N1O6P2
C45H55N1O6P2
Acta Crystallographica Section C (2000) 56, 11 1404-1406
a=11.7040(10)Å b=11.751(2)Å c=15.640(2)Å
α=91.750(10)° β=92.180(10)° γ=90.550(10)°
1,3-[Bis(N-2-oxyphenylsalicylydene)]propane
C29H26N2O4
Acta Crystallographica Section C (2004) 60, 11 o803-o805
a=14.3665(10)Å b=17.1608(18)Å c=19.762(3)Å
α=90.00° β=90.00° γ=90.00°
C14H14Cl4N5O2P3
C14H14Cl4N5O2P3
Acta Crystallographica Section C (2004) 60, 7 o461-o463
a=9.045(2)Å b=11.647(3)Å c=12.225(2)Å
α=103.663(17)° β=107.458(19)° γ=109.78(2)°
4,4',6',6'-Tetrachloro-3,4-dihydro-3-(6-methylpyridin-2-yl)spiro[1,3,2- benzoxazaphosphinine-2,2'-(2λ^5^,4λ^5^,6λ^5^-cyclotriphosphazene)]
C13H12Cl4N5OP3
Acta Crystallographica Section C (2004) 60, 9 o639-o641
a=8.98340(10)Å b=9.5110(2)Å c=11.9857(2)Å
α=82.131(2)° β=87.5980(10)° γ=81.992(2)°
C13H8Cl4N5O6P3
C13H8Cl4N5O6P3
Acta Crystallographica Section C (2000) 56, 1 90-92
a=16.3170(10)Å b=8.0470(10)Å c=16.8020(10)Å
α=90° β=96.970(10)° γ=90°